Introducing SanaCurrents Introducing SanaCurrents, a research service for the serious and sophisticated biotech investor. Founder of SanaCurrents, Bill Langbein, finally brings his service to the mainstream to enable biotech investors to track catalysts through the lens of varying levels of […]
This content is for members only
We believe that REPRO MED SYS INC (OOTC:REPR) can more than double from its recent trading price, but there are risks. The Company has been under a cloud since the FDA issued a warning letter concerning the company’s Freedom 60 Syringe […]
Medical Device Company EDAP TMS Treats Prostate Cancer. Revenue & Profits Has Us Taking a Closer Look. By Maj Soueidan, President GeoInvesting Good Morning. I hope your day is going well. The past 8 trading days have certainly been volatile. In […]
We have been highlighting the continuous open market purchases of Repro-Med Systems (OOTC:REPR) shares by Joseph Manko of Horton Capital Management the last several months. The last filing was on February 17,2016 which disclosed a purchase of 21,900 shares bringing Horton […]
GeoInvesting has been covering Repro-Med Systems (OOTC:REPR) for several years and in mid 2014, we explained that the company’s history of growing revenues would eventually garner investor attention. Yesterday, the stock’s price matched its 52-week high, which also happens to be the […]
Today, Mindray Medical (NYSE:MR) announced a receipt of a revised non-binding proposal to acquire the company at US$27 per ADS or US$27 per ordinary share. On September 3, 2015, 7 days ago, we sent out a premium note to members that the original go-private […]
The GeoTeam has been monitoring developments that might impact REPRO MED SYS INC (OOTC:REPR) and its flagship product, the FREEDOM60 pump (mechanical infusion pump system) and related needle sets used to deliver medication to primary immune deficiency patients. We noted that […]